← Back to Search

Everolimus for Tumors

N/A
Waitlist Available
Research Sponsored by Sinai Hospital of Baltimore
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day
Awards & highlights

Study Summary

The purpose of this research study is to understand if platelets in the blood become more active during cancer and specially advanced stages of cancer, in the future the investigators want to see if reducing platelet activity can improve survival in advanced cancer.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Blood Platelets
Secondary outcome measures
Release of vasoactive substances, e.g. TGF Beta

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: CasesActive Control1 Intervention
Patients with cancer whose platelets are examined
Group II: ControlPlacebo Group2 Interventions
Patients without cancer whose platelets are examined for comparison

Find a Location

Who is running the clinical trial?

Sinai Hospital of BaltimoreLead Sponsor
7 Previous Clinical Trials
358 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Etiology of the Platelet-Cancer Metastatic Pathway - A Study of Inflammatory Markers, Platelet Characteristics and Metastatic Surrogates in Cancer Patients and Controls
Kenneth Miller, M.D. 2014. "Etiology of the Platelet-Cancer Metastatic Pathway - A Study of Inflammatory Markers, Platelet Characteristics and Metastatic Surrogates in Cancer Patients and Controls". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02450175.
All > Cte
~5 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top